Skip to main content
Clinical Trials/ISRCTN11447662
ISRCTN11447662
Active, not recruiting
未知

A randomised controlled trial of regular MRI scans compared to standard care in patients with prostate cancer managed using active surveillance

Imperial College London0 sites1,263 target enrollmentFebruary 7, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Imperial College London
Enrollment
1263
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2024
End Date
June 30, 2032
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 years or above (no upper limit)
  • 2\. Patients with a prostate (either cis\-male gender or trans\-female gender with no prior androgen deprivation hormone use at all)
  • 3\. Diagnostic bi\-parametric or multiparametric MRI
  • 4\. Diagnostic systematic biopsy \+/\- targeted biopsy
  • 5\. A histological diagnosis of localised prostate cancer of low or intermediate risk

Exclusion Criteria

  • 1\. On active surveillance for greater than 9 months prior to the screening date
  • 2\. Contraindication to MRI or gadolinium contrast
  • 3\. Previous hip replacement to both hips
  • 4\. Contraindication to performing a biopsy guided by a transrectal ultrasound probe

Outcomes

Primary Outcomes

Not specified

Similar Trials